GLP-1 Receptor Agonist Market Share, Trends, Revenue, Competition, Growth Drivers, Challenges, CAGR Status and Business Opportunities Till 2033: SPER Market Research
GLP-1 receptor agonists are a type of medication primarily prescribed for managing type 2 diabetes and have recently gained attention for their effectiveness in treating obesity. They function similarly to glucagon-like peptide-1 (GLP-1), a hormone that increases insulin production, delays stomach emptying, decreases glucagon release, and encourages feelings of fullness in response to meals. These medications aid in improving blood sugar homeostasis and may promote weight loss by increasing insulin sensitivity and decreasing hunger. Examples that have also demonstrated cardiovascular benefits include semaglutide and ligarglutide. According to SPER Market Research, ‘Global GLP-1 Receptor Agonist Market Size- By Product, By Application, By Route of Administration, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ states that the Global GLP-1 Receptor Agonist Market is estimated to reach USD 266.54 billion by 2033 with a CAGR of 21.9%. Dri...